Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
about
Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?Biocomposites and hybrid biomaterials based on calcium orthophosphatesPatents in genomics and human geneticsTranslating personalized medicine using new genetic technologies in clinical practice: the ethical issuesPatently unpatentable: implications of the Myriad court decision on genetic diagnostics.DNA patents and diagnostics: not a pretty picture3-D Scaffold Platform for Optimized Non-viral Transfection of Multipotent Stem Cells.Area-specific cell stimulation via surface-mediated gene transfer using apatite-based composite layersGene patents: a broken incentives systemCystic Fibrosis Patents: A Case Study of Successful Licensing.Fabrication of DNA-antibody-apatite composite layers for cell-targeted gene transfer.Nanotopography-mediated reverse uptake for siRNA delivery into neural stem cells to enhance neuronal differentiation.Public health and the common good.Coprecipitation of DNA-lipid complexes with apatite and comparison with superficial adsorption for gene transfer applications.Fabrication of a DNA-lipid-apatite composite layer for efficient and area-specific gene transfer.
P2860
Q27026343-A9279604-0CC7-46BA-A8D1-783848D3AF52Q28709942-BA120D1E-BEDF-48C2-8893-FFD4DB9B2D4CQ28749392-FB88B190-57E1-404A-902E-E55BC8261FC5Q34159801-E2896D18-58E2-4F69-9451-258A7E89D523Q34204070-1F4B6794-FD7A-4B1E-AC4F-71A8EECFE41FQ34520116-C1FC67C0-9012-4D35-AC04-C9F870BCA700Q34755064-2AECB1AB-B26A-42D4-B683-A54ECCCE57B4Q35585655-CC95B5ED-2891-4CCA-8FC5-C67C4DBE5FCEQ37284893-9D15FD3E-8A0B-4C63-98EB-8FA09833DC53Q37301809-17E1D4B3-92D1-46EC-953B-2779A1834604Q37399921-DB4E1E73-44CD-4964-B74C-769AD1C981C2Q39175241-7DD649A7-BA1C-428E-9E0B-82F13D712B51Q42243013-F4111D09-00C2-4596-B47A-D2A139050F56Q51750658-E65BD67E-7DF8-465B-9AD0-841A15093E1DQ51760727-2C1471F6-7002-46B7-92B2-B4E46ACBC7F5
P2860
Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@ast
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@en
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@nl
type
label
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@ast
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@en
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@nl
prefLabel
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@ast
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@en
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@nl
P2093
P2860
P1433
P1476
Impact of gene patents and lic ...... c testing for cystic fibrosis.
@en
P2093
Chris Conover
Christopher Heaney
Subhashini Chandrasekharan
Tamara James
P2860
P2888
P304
P356
10.1097/GIM.0B013E3181D7CF7D
P407
P433
P577
2010-04-01T00:00:00Z
P6179
1024204995